SIC
ABEO icon

SJS Investment Consulting’s Abeona Therapeutics ABEO Stock Holding History

SJS Investment Consulting’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$124 Buy
+20
New +$110 ﹤0.01% 2566

Other funds holding ABEO

NFT
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
MSR
Main Street Research Lakeville, Connecticut $2.12B AUM 67.44% 1-Year Est. Return
AWM
Aries Wealth Management Portland, Maine $509M AUM 25.6% 1-Year Est. Return
EI
Ethic Inc New York $8.02B AUM 45.39% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
KA
Kovack Advisors Ft. Lauderdale, Florida $2.08B AUM 38.95% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

SJS Investment Consulting's ABEO Position: Q2 2026 in Review

SJS Investment Consulting opened a new position in Abeona Therapeutics (ABEO) in Q2 2026: 20 shares worth $124. The stake represents ﹤0.01% of the portfolio and ranks #2566 among its holdings.

20 funds tracked by Wall St. Rank hold ABEO as of Q2 2026.

  • SJS Investment Consulting held 20 shares of Abeona Therapeutics worth $124 as of Q2 2026.
  • Abeona Therapeutics was a new SJS Investment Consulting position in Q2 2026.
  • Abeona Therapeutics made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #2566 holding.
  • 20 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.